The Sweden pharmaceutical market size was $6.2 billion in 2021. Likewise, the Swedish medical devices market size was $2.1 billion in 2021 and is expected to achieve a CAGR of more than 3% during 2022-2027. The growth in the pharmaceutical market is attributed to the growing aging population; lifestyle-related disease conditions such as diabetes and obesity; and increased prevalence of chronic diseases such as cardiovascular conditions, stroke, and cancer. 

To gain more information on the Sweden pharmaceutical market forecast, download a free report sample

The key import partners of pharmaceutical products in Sweden are Belgium, the US, Denmark, the Netherlands, and Germany among others. Germany accounts for the highest percentage of the import business. The key export partners of Swedish pharmaceutical products are Germany, China, the US, Japan, and Norway, among others, in 2021. The US accounts for the highest percentage of the export business. The key segments in the Sweden medical devices market are hospital supplies, cardiovascular devices, general surgery devices, orthopedic devices, and wound care management among others. In 2021, hospital supplies had the highest share of Sweden’s medical devices market, followed by cardiovascular devices and orthopedic devices.